2023 JDD Welcome Kit The Journal of Drugs in Dermatology (JDD) and its sponsors are welcoming the latest dermatology residency graduates into the specialty. Graduates from 2023 are each receiving…
Read More
by Allison Sit A Journal of Drugs in Dermatology study on the availability of oral minoxidil made news in several media outlets, including NBC News, HealthDay, Practical Dermatology and Dermatology…
Read More
By Allison Sit Physician organizations including the American Academy of Dermatology (AAD) are raising alarm about finalized cuts to the Medicare physician fee schedule for 2024. AAD President Terrence A.…
Read More
iTunes TuneIn Spotify Dr. Beth McLellan & Adam Friedman, MD, FAAD Mo’ targeted therapies, mo’skin problems. Some may say, “Bring on the problems” – but why should they have to? Supportive Oncodermatology…
Read More
By Allison Sit A new study in the Journal of the American Academy of Academy of Dermatology showed children with atopic dermatitis (AD) are significantly more likely to have positive…
Read More
Healio featured several September JDD studies in its recent dermatology news coverage including a study on using fractional lasers for skin cancer prevention. The study, “Fractional Laser for Prevention of…
Read More
The JDD Corner is NOW LIVE! The JDD Corner is your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor…
Read More
By Allison Sit Almirall is debuting its “Atopic Museum” in observance of World Atopic Eczema Day on September 14. The museum is an online space designed to foster a deeper…
Read More
Dermatology Times featured a JDD study on whether race plays a factor in access to biologics. The study, “No Racial Differences Found in Access to Biologics: A Population-Based Study of…
Read More
By Allison Sit A research project that seeks to develop deep learning algorithms that will predict which actinic keratoses (AKs) are likely to progress to squamous cell carcinomas (SCCs) has…
Read More
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote, “Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe…
Read More
Sponsored by Join the Journal of Drugs in Dermatology and Nutrafol in recognizing Hair Loss Awareness Month this August. This month aims to raise awareness how common hair thinning…
Read More
